Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 114

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Recent Developments in Nitric Oxide Donors and Delivery for Antimicrobial and Anti-Biofilm Applications

Poh, Wee Han, Rice, Scott A. · 2022 · Molecules

Abstract

The use of nitric oxide (NO) is emerging as a promising, novel approach for the treatment of antibiotic resistant bacteria and biofilm infections. Depending on the concentration, NO can induce biofilm dispersal, increase bacteria susceptibility to antibiotic treatment, and induce cell damage or cell death via the formation of reactive oxygen or reactive nitrogen species. The use of NO is, however, limited by its reactivity, which can affect NO delivery to its target site and result in off-target effects. To overcome these issues, and enable spatial or temporal control over NO release, various strategies for the design of NO-releasing materials, including the incorporation of photo-activable, charge-switchable, or bacteria-targeting groups, have been developed. Other strategies have focused on increased NO storage and delivery by encapsulation or conjugation of NO donors within a single polymeric framework. This review compiles recent developments in NO drugs and NO-releasing materials designed for applications in antimicrobial or anti-biofilm treatment and discusses limitations and variability in biological responses in response to the use of NO for bacterial eradiation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules27030674

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 154

  1. Cox, 2013, Intrinsic antibiotic resistance: Mechanisms, origins, challenges and solutions, Int. J. Med. Microbiol., 303, 287, 10.1016/j.ijmm.2013.02.009 · DOI · Paper page
  2. Abe, 2020, Biofilms: Hot spots of horizontal gene transfer (HGT) in aquatic environments, with a focus on a new HGT mechanism, FEMS Microbiol. Ecol., 96, fiaa031, 10.1093/femsec/fiaa031 · DOI · Paper page
  3. Davies, 2003, Understanding biofilm resistance to antibacterial agents, Nat. Rev. Drug Discov., 2, 114, 10.1038/nrd1008 · DOI · Paper page
  4. Srey, 2013, Biofilm formation in food industries: A food safety concern, Food Control, 31, 572, 10.1016/j.foodcont.2012.12.001 · DOI · Paper page
  5. 2018, Marine Biofilms: A Successful Microbial Strategy with Economic Implications, Front. Mar. Sci., 5, 126, 10.3389/fmars.2018.00126 · DOI · Paper page
  6. Barraud, 2006, Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa, J. Bacteriol., 188, 7344, 10.1128/JB.00779-06 · DOI · Paper page
  7. Beasley, 2013, Methicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development, J. Biol. Chem., 288, 6417, 10.1074/jbc.M112.448738 · DOI
  8. Levine, 2012, Characterization of the Role of Nitric Oxide and Its Clinical Applications, Cardiology, 122, 55, 10.1159/000338150 · DOI · Paper page
  9. Cai, 2021, NO donors and NO delivery methods for controlling biofilms in chronic lung infections, Appl. Microbiol. Biotechnol., 105, 3931, 10.1007/s00253-021-11274-2 · DOI · Paper page
  10. Grasemann, 2012, Nitric Oxide and L-Arginine Deficiency in Cystic Fibrosis, Curr. Pharm. Des., 18, 726, 10.2174/138161212799315911 · DOI
  11. Rouillard, 2020, Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models, J. Cyst. Fibros., 19, 1004, 10.1016/j.jcf.2020.03.004 · DOI
  12. Choi, 2020, Chitosan-based nitric oxide-releasing dressing for anti-biofilm and in vivo healing activities in MRSA biofilm-infected wounds, Int. J. Biol. Macromol., 142, 680, 10.1016/j.ijbiomac.2019.10.009 · DOI
  13. Eiserich, 1998, Pathophysiology of nitric oxide and related species: Free radical reactions and modification of biomolecules, Mol. Asp. Med., 19, 221, 10.1016/S0098-2997(99)00002-3 · DOI · Paper page
  14. Misra, 1991, DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors, Science, 254, 1001, 10.1126/science.1948068 · DOI · Paper page
  15. Seabra, A.B. (2017). Chapter 7-Nitric Oxide Donors as Antimicrobial Agents. Nitric Oxide Donors, Academic Press.
  16. Ridnour, 2004, The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations, Biol. Chem., 385, 1, 10.1515/BC.2004.001 · DOI · Paper page
  17. Li, 2018, Chitosan-graft-PAMAM loading nitric oxide for efficient antibacterial application, Chem. Eng. J., 347, 923, 10.1016/j.cej.2018.04.159 · DOI
  18. Shen, 2019, Visible-Light-Triggered Self-Reporting Release of Nitric Oxide (NO) for Bacterial Biofilm Dispersal, Macromolecules, 52, 7668, 10.1021/acs.macromol.9b01252 · DOI
  19. Hou, 2020, Precisely Structured Nitric-Oxide-Releasing Copolymer Brush Defeats Broad-Spectrum Catheter-Associated Biofilm Infections In Vivo, Acs Cent. Sci., 6, 2031, 10.1021/acscentsci.0c00755 · DOI
  20. Yepuri, 2013, Synthesis of cephalosporin-3 ‘-diazeniumdiolates: Biofilm dispersing NO-donor prodrugs activated by beta-lactamase, Chem. Commun., 49, 4791, 10.1039/c3cc40869h · DOI
  21. Fei, 2020, Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections, J. Med. Chem., 63, 9127, 10.1021/acs.jmedchem.9b01832 · DOI
  22. Crane, 2010, Bacterial nitric oxide synthases, Annu. Rev. Biochem., 79, 445, 10.1146/annurev-biochem-062608-103436 · DOI · Paper page
  23. Poole, 2018, Chapter Five-Emerging Roles of Nitric Oxide Synthase in Bacterial Physiology, Advances in Microbial Physiology, Volume 72, 147, 10.1016/bs.ampbs.2018.01.006 · DOI
  24. Mihu, 2017, Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model, Antimicrob. Agents Chemother., 61, e02020-16, 10.1128/AAC.02020-16 · DOI
  25. Howlin, 2017, Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis, Mol. Ther., 25, 2104, 10.1016/j.ymthe.2017.06.021 · DOI · Paper page
  26. Arora, 2015, Nitric Oxide Regulation of Bacterial Biofilms, Biochemistry, 54, 3717, 10.1021/bi501476n · DOI · Paper page
  27. Deja, 2003, Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis, Am. J. Respir. Crit. Care Med., 168, 281, 10.1164/rccm.200207-640OC · DOI
  28. Hausladen, 1996, Nitrosative Stress: Activation of the Transcription Factor OxyR, Cell, 86, 719, 10.1016/S0092-8674(00)80147-6 · DOI · Paper page
  29. Vallance, 1998, Nitric oxide as an antimicrobial agent: Does NO always mean NO?, Gut, 42, 313, 10.1136/gut.42.3.313 · DOI
  30. Kuang, 2021, Inactivation of Nitrite-Dependent Nitric Oxide Biosynthesis Is Responsible for Overlapped Antibiotic Resistance between Naturally and Artificially Evolved Pseudomonas aeruginosa, mSystems, 6, e00732-21, 10.1128/mSystems.00732-21 · DOI
  31. Kerr, 2004, Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae, Microb. Pathog., 36, 303, 10.1016/j.micpath.2004.02.001 · DOI
  32. Yang, 2020, Antibacterial action of nitric oxide-releasing hyperbranched polymers against ex vivo dental biofilms, Dent. Mater., 36, 635, 10.1016/j.dental.2020.03.012 · DOI
  33. Barnes, 2013, Optimal dosing regimen of nitric oxide donor compounds for the reduction of Pseudomonas aeruginosa biofilm and isolates from wastewater membranes, Biofouling, 29, 203, 10.1080/08927014.2012.760069 · DOI
  34. Zhu, 2018, Nitric Oxide-Mediated Induction of Dispersal in Pseudomonas aeruginosa Biofilms Is Inhibited by Flavohemoglobin Production and Is Enhanced by Imidazole, Antimicrob. Agents Chemother., 62, e01832-17, 10.1128/AAC.01832-17 · DOI · Paper page
  35. Hasan, 2018, Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate, Eur. J. Pharm. Sci., 115, 50, 10.1016/j.ejps.2018.01.003 · DOI
  36. Ren, 2016, Efficient Eradication of Mature Pseudomonas aeruginosa Biofilm via Controlled Delivery of Nitric Oxide Combined with Antimicrobial Peptide and Antibiotics, Front. Microbiol., 7, 1260, 10.3389/fmicb.2016.01260 · DOI
  37. Zemke, 2020, Antimicrobial Synergism Toward Pseudomonas aeruginosaby Gallium(III) and Inorganic Nitrite, Front. Microbiol., 11, 2113, 10.3389/fmicb.2020.02113 · DOI
  38. Rouillard, 2021, Exogenous Nitric Oxide Improves Antibiotic Susceptibility in Resistant Bacteria, ACS Infect. Dis., 7, 23, 10.1021/acsinfecdis.0c00337 · DOI
  39. Ouadrhiri, 1999, Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon, Antimicrob. Agents Chemother., 43, 1242, 10.1128/AAC.43.5.1242 · DOI
  40. Huang, 2021, Nitric oxide pretreatment enhances ofloxacin susceptibility of biofilm concomitant with exopolysaccharide depletion, Colloid Interface Sci. Commun., 41, 100371, 10.1016/j.colcom.2021.100371 · DOI
  41. Allan, 2016, Low Concentrations of Nitric Oxide Modulate Streptococcus pneumoniae Biofilm Metabolism and Antibiotic Tolerance, Antimicrob. Agents Chemother., 60, 2456, 10.1128/AAC.02432-15 · DOI
  42. Nandanwar, 2021, Growth medium and nitric oxide alter Mycobacterium abscessus morphotype and virulence, Microbiol. Res., 253, 126887, 10.1016/j.micres.2021.126887 · doi:10.1016/j.micres.2021.126887
  43. Krause, 2016, Aminoglycosides: An Overview, Cold Spring Harb. Perspect. Med., 6, a027029, 10.1101/cshperspect.a027029 · DOI · Paper page
  44. McCollister, 2011, Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake, Antimicrob. Agents Chemother., 55, 2189, 10.1128/AAC.01203-10 · DOI
  45. Nguyen, 2016, Co-delivery of nitric oxide and antibiotic using polymeric nanoparticles, Chem. Sci., 7, 1016, 10.1039/C5SC02769A · DOI · Paper page
  46. Duan, 2021, Photoresponsive Vesicles Enabling Sequential Release of Nitric Oxide (NO) and Gentamicin for Efficient Biofilm Eradication, Macromol. Rapid Commun., 42, e2000759, 10.1002/marc.202000759 · DOI
  47. Wiegand, 2021, Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia, Redox. Biol., 39, 101826, 10.1016/j.redox.2020.101826 · DOI
  48. Michaelsen, 2020, Gaseous Nitric Oxide (gNO) as a Potential Antimicrobial Therapy during Ex Vivo Lung Perfusion: An Efficacy and Safety Study, J. Heart Lung Transplant., 39, S46, 10.1016/j.healun.2020.01.1217 · doi:10.1016/j.healun.2020.01.1217
  49. Bogdanovski, 2020, Antibacterial activity of high-dose nitric oxide against pulmonary Mycobacterium abscessus disease, Access Microbiol., 2, acmi000154, 10.1099/acmi.0.000154 · DOI
  50. Bentur, 2020, Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection, J. Cyst. Fibros., 19, 225, 10.1016/j.jcf.2019.05.002 · DOI
  51. Bartley, 2020, High-Dose Inhaled Nitric Oxide as Adjunct Therapy in Cystic Fibrosis Targeting Burkholderia multivorans, Case Rep. Pediatri., 2020, 1536714
  52. Zhao, 2021, Light-Triggered Nitric Oxide Release by a Photosensitizer to Combat Bacterial Biofilm Infections, Chem. A Eur. J., 27, 5453, 10.1002/chem.202004698 · DOI
  53. Boce, 2019, Effect of trans(NO, OH)- RuFT(CI)(OH)NO (PF6) ruthenium nitrosyl complex on methicillin-resistant Staphylococcus epidermidis, Sci. Rep., 9, 4867, 10.1038/s41598-019-41222-0 · DOI
  54. Cariello, 2012, Bactericidal effect of S-nitrosothiols against clinical isolates from keratitis, Clin. Ophthalmol., 6, 1907, 10.2147/OPTH.S34830 · DOI
  55. Barnes, 2015, Nitric oxide treatment for the control of reverse osmosis membrane biofouling, Appl. Environ. Microbiol., 81, 2515, 10.1128/AEM.03404-14 · DOI
  56. Marvasi, 2014, Systematic analysis of the ability of Nitric Oxide donors to dislodge biofilms formed by Salmonella enterica and Escherichia coli O157:H7, AMB Express, 4, 42, 10.1186/s13568-014-0042-y · DOI
  57. Poh, 2017, Furoxan Nitric Oxide Donors Disperse Pseudomonas aeruginosa Biofilms, Accelerate Growth, and Repress Pyoverdine Production, ACS Chem. Biol., 12, 2097, 10.1021/acschembio.7b00256 · DOI
  58. Orlandi, 2018, Anti-Pseudomonas activity of 3-nitro-4-phenylfuroxan, Microbiology, 164, 1557, 10.1099/mic.0.000730 · DOI
  59. Allan, 2017, Cephalosporin-NO-donor prodrug PYRRO-C3D shows beta-lactam-mediated activity against Streptococcus pneumoniae biofilms, Nitric Oxide Biol. Chem., 65, 43, 10.1016/j.niox.2017.02.006 · DOI
  60. Barraud, 2012, Cephalosporin-3 ‘-diazeniumdiolates: Targeted NO-Donor Prodrugs for Dispersing Bacterial Biofilms, Angew. Chem. Int. Ed., 51, 9057, 10.1002/anie.201202414 · DOI · Paper page
  61. Collins, 2017, Cephalosporin-3 ‘-Diazeniumdiolate NO Donor Prodrug PYRRO-C3D Enhances Azithromycin Susceptibility of Nontypeable Haemophilus influenzae Biofilms, Antimicrob. Agents Chemother., 61, e02086-16, 10.1128/AAC.02086-16 · DOI
  62. Rineh, 2020, Discovery of Cephalosporin-3 ‘-Diazeniumdiolates That Show Dual Antibacterial and Antibiofilm Effects against Pseudomonas aeruginosa Clinical Cystic Fibrosis Isolates and Efficacy in a Murine Respiratory Infection Model, Acs Infect. Dis., 6, 1460, 10.1021/acsinfecdis.0c00070 · DOI
  63. Soren, 2020, Cephalosporin nitric oxide-donor prodrug DEA-C3D disperses biofilms formed by clinical cystic fibrosis isolates of Pseudomonas aeruginosa, J. Antimicrob. Chemother., 75, 117, 10.1093/jac/dkz378 · DOI
  64. Kutty, 2013, Design, Synthesis, and Evaluation of Firnbrolide-Nitric Oxide Donor Hybrids as Antimicrobial Agents, J. Med. Chem., 56, 9517, 10.1021/jm400951f · DOI
  65. Frostell, 1991, Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction, Circulation, 83, 2038, 10.1161/01.CIR.83.6.2038 · DOI · Paper page
  66. Ghaffari, 2007, Efficacy of gaseous nitric oxide in the treatment of skin and soft tissue infections, Wound Repair Regen, 15, 368, 10.1111/j.1524-475X.2007.00239.x · DOI
  67. Sulemankhil, 2012, Prevention and Treatment of Virulent Bacterial Biofilms with an Enzymatic Nitric Oxide-Releasing Dressing, Antimicrob. Agents Chemother., 56, 6095, 10.1128/AAC.01173-12 · DOI
  68. Waite, 2018, Activity of a nitric oxide-generating wound treatment system against wound pathogen biofilms, Int. J. Antimicrob. Agents, 52, 338, 10.1016/j.ijantimicag.2018.04.009 · DOI
  69. Hall, 2020, Mode of Nitric Oxide Delivery Affects Antibacterial Action, ACS Biomater. Sci. Eng., 6, 433, 10.1021/acsbiomaterials.9b01384 · DOI
  70. Chau, 2019, High Efficacy of High-dose Nitric Oxide and its Synergistic Effect with Antibiotics against Mycobacterium Abscessus, Eur. Respir. J., 54, OA4950
  71. Salguero, 2002, Inhaled nitric oxide and methemoglobin in full-term infants with persistent pulmonary hypertension of the newborn, Pulm. Pharm. Ther., 15, 1, 10.1006/pupt.2001.0311 · DOI
  72. Young, 1994, Methaemoglobin production in normal adults inhaling low concentrations of nitric oxide, Intensive Care Med., 20, 581, 10.1007/BF01705726 · DOI
  73. Miller, 2009, Gaseous nitric oxide bactericidal activity retained during intermittent high-dose short duration exposure, Nitric Oxide, 20, 16, 10.1016/j.niox.2008.08.002 · DOI
  74. Schulz, 1982, Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate, Klin. Wochenschr., 60, 1393, 10.1007/BF01716244 · DOI
  75. Seabra, 2004, Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin, Br. J. Derm., 151, 977, 10.1111/j.1365-2133.2004.06213.x · DOI
  76. Pankotai, 2011, Current developments in the therapeutic potential of S-nitrosoglutathione, an endogenous NO-donor molecule, Curr. Pharm. Biotechnol., 12, 1368, 10.2174/138920111798280983 · DOI
  77. 2016, S-Nitrosothiols as Platforms for Topical Nitric Oxide Delivery, Basic Clin. Pharmacol. Toxicol., 119, 49, 10.1111/bcpt.12588 · DOI
  78. Lu, 2015, S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents, Acta Biomater., 12, 62, 10.1016/j.actbio.2014.10.028 · DOI
  79. Denadai, 2019, Long-term decomposition of aqueous S-nitrosoglutathione and S-nitroso-N-acetylcysteine: Influence of concentration, temperature, pH and light, Nitric Oxide, 84, 30, 10.1016/j.niox.2019.01.002 · DOI
  80. Zhelyaskov, 1998, Control of NO concentration in solutions of nitrosothiol compounds by light, Photochem. Photobiol., 67, 282, 10.1111/j.1751-1097.1998.tb05200.x · DOI
  81. Kumari, 2014, The design of nitric oxide donor drugs: S-nitrosothiol tDodSNO is a superior photoactivated donor in comparison to GSNO and SNAP, Eur. J. Pharmacol., 737, 168, 10.1016/j.ejphar.2014.05.012 · DOI
  82. Riccio, 2012, Photoinitiated nitric oxide-releasing tertiary S-nitrosothiol-modified xerogels, ACS Appl. Mater. Interfaces, 4, 796, 10.1021/am201443r · DOI
  83. Keefer, 2011, Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances, ACS Chem. Biol., 6, 1147, 10.1021/cb200274r · DOI · Paper page
  84. Ahonen, 2019, Antibiofilm Efficacy of Nitric Oxide-Releasing Alginates against Cystic Fibrosis Bacterial Pathogens, ACS Infect. Dis., 5, 1327, 10.1021/acsinfecdis.9b00016 · DOI
  85. Backlund, 2016, Anti-biofilm action of nitric oxide-releasing alkyl-modified poly(amidoamine) dendrimers against Streptococcus mutans, Acta Biomater., 29, 198, 10.1016/j.actbio.2015.10.021 · DOI
  86. Worley, 2015, Anti-Biofilm Efficacy of Dual-Action Nitric Oxide-Releasing Alkyl Chain Modified Poly(amidoamine) Dendrimers, Mol. Pharm., 12, 1573, 10.1021/acs.molpharmaceut.5b00006 · DOI
  87. Worley, 2014, Nitric Oxide-Releasing Quaternary Ammonium-Modified Poly(amidoamine) Dendrimers as Dual Action Antibacterial Agents, Bioconjugate Chem., 25, 918, 10.1021/bc5000719 · DOI
  88. Lu, 2011, Structurally Diverse Nitric Oxide-Releasing Poly(propylene Imine) Dendrimers, Chem. Mater., 23, 4227, 10.1021/cm201628z · DOI
  89. Hetrick, 2008, Bactericidal efficacy of nitric oxide-releasing silica nanoparticles, ACS Nano, 2, 235, 10.1021/nn700191f · DOI · Paper page
  90. Adnan, 2018, Exploiting the Versatility of Polydopamine-Coated Nanoparticles to Deliver Nitric Oxide and Combat Bacterial Biofilm, Macromol. Rapid Commun., 39, e1800159, 10.1002/marc.201800159 · DOI
  91. Zhu, 2019, Nitric Oxide and Iron Signaling Cues Have Opposing Effects on Biofilm Development in Pseudomonas aeruginosa, Appl. Environ. Microbiol., 85, e02175-18, 10.1128/AEM.02175-18 · DOI
  92. Cai, 2020, Optimization of nitric oxide donors for investigating biofilm dispersal response in Pseudomonas aeruginosaclinical isolates, Appl. Microbiol. Biotechnol., 104, 8859, 10.1007/s00253-020-10859-7 · DOI
  93. Gasco, 2004, NO donors: Focus on furoxan derivatives, Pure Appl. Chem., 76, 973, 10.1351/pac200476050973 · doi:10.1351/pac200476050973
  94. Sorba, 1997, Water soluble furoxan derivatives as NO prodrugs, J. Med. Chem., 40, 463, 10.1021/jm960379t · DOI
  95. Guo, 2017, Ruthenium nitrosyl functionalized graphene quantum dots as an efficient nanoplatform for NIR-light-controlled and mitochondria-targeted delivery of nitric oxide combined with photothermal therapy, Chem. Commun., 53, 3253, 10.1039/C7CC00670E · DOI
  96. Rose, 2008, Photoactive ruthenium nitrosyls: Effects of light and potential application as NO donors, Coord. Chem. Rev., 252, 2093, 10.1016/j.ccr.2007.11.011 · DOI · Paper page
  97. Taunk, 2018, Dual-Action Biomaterial Surfaces with Quorum Sensing Inhibitor and Nitric Oxide To Reduce Bacterial Colonization, ACS Biomater. Sci. Eng., 4, 4174, 10.1021/acsbiomaterials.8b00816 · DOI
  98. Lu, 2014, Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents, Biomaterials, 35, 1716, 10.1016/j.biomaterials.2013.11.015 · DOI · Paper page
  99. Reighard, 2015, Disruption and eradication of P. aeruginosa biofilms using nitric oxide-releasing chitosan oligosaccharides, Biofouling, 31, 775, 10.1080/08927014.2015.1107548 · DOI · Paper page
  100. Tang, 2016, Managing bacterial biofilms with chitosan-based polymeric nitric oxides: Inactivation of biofilm bacteria and synergistic effects with antibiotics, J. Bioact. Compat. Polym., 31, 393, 10.1177/0883911515623798 · DOI
  101. Hasan, 2017, Controlled and Localized Nitric Oxide Precursor Delivery From Chitosan Gels to Staphylococcus aureus Biofilms, J. Pharm. Sci., 106, 3556, 10.1016/j.xphs.2017.08.006 · DOI
  102. Sundaram, 2016, Antimicrobial and Physicochemical Characterization of Biodegradable, Nitric Oxide-Releasing Nanocellulose–Chitosan Packaging Membranes, J. Agric. Food Chem., 64, 5260, 10.1021/acs.jafc.6b01936 · DOI
  103. Liu, 2020, Chitosan derivatives co-delivering nitric oxide and methicillin for the effective therapy to the methicillin-resistant S. aureus infection, Carbohydr. Polym., 234, 115928, 10.1016/j.carbpol.2020.115928 · DOI
  104. Ahonen, 2018, Nitric Oxide-Releasing Alginates, Biomacromolecules, 19, 1189, 10.1021/acs.biomac.8b00063 · DOI
  105. Rouillard, 2020, Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins, ACS Infect. Dis., 6, 1940, 10.1021/acsinfecdis.0c00246 · DOI
  106. Jin, 2018, Nitric Oxide-Releasing Cyclodextrins, J. Am. Chem Soc., 140, 14178, 10.1021/jacs.8b07661 · DOI
  107. Hetrick, 2009, Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles, Biomaterials, 30, 2782, 10.1016/j.biomaterials.2009.01.052 · DOI · Paper page
  108. Carpenter, 2011, Influence of Scaffold Size on Bactericidal Activity of Nitric Oxide-Releasing Silica Nanoparticles, ACS Nano, 5, 7235, 10.1021/nn202054f · DOI
  109. Slomberg, 2013, Role of Size and Shape on Biofilm Eradication for Nitric Oxide-Releasing Silica Nanoparticles, ACS Appl. Mater. Interfaces, 5, 9322, 10.1021/am402618w · DOI · Paper page
  110. Backlund, 2015, Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide, J. Dent. Res., 94, 1092, 10.1177/0022034515589314 · DOI
  111. Martinez, 2009, Antimicrobial and Healing Efficacy of Sustained Release Nitric Oxide Nanoparticles Against Staphylococcus Aureus Skin Infection, J. Investig. Dermatol., 129, 2463, 10.1038/jid.2009.95 · DOI · Paper page
  112. Sadrearhami, 2017, Biofilm dispersal using nitric oxide loaded nanoparticles fabricated by photo-PISA: Influence of morphology, Chem. Commun., 53, 12894, 10.1039/C7CC07293G · DOI
  113. Hasan, 2017, Biodegradable nitric oxide precursor-loaded micro- and nanoparticles for the treatment of Staphylococcus aureus biofilms, J. Mater. Chem. B, 5, 1005, 10.1039/C6TB03290G · DOI
  114. Hasan, 2019, PEI/NONOates-doped PLGA nanoparticles for eradicating methicillin-resistant Staphylococcus aureus biofilm in diabetic wounds via binding to the biofilm matrix, Mater. Sci. Eng. C Mater. Biol. Appl., 103, 109741, 10.1016/j.msec.2019.109741 · DOI
  115. Zhang, 2020, Effects of isosorbide mononitrate loaded nanoparticles conjugated with anti-Staphylococcus aureus α-toxin on Staphylococcus aureus biofilms, Exp. Ther. Med., 19, 1267
  116. Liu, 2021, Surface charge switchable nanoparticles capable of controlled nitric oxide release for the treatment of acidity-associated bacterial infections, Polym. Chem., 12, 1023, 10.1039/D0PY01460E · DOI
  117. Hu, 2020, Surface Charge Switchable Supramolecular Nanocarriers for Nitric Oxide Synergistic Photodynamic Eradication of Biofilms, ACS Nano, 14, 347, 10.1021/acsnano.9b05493 · DOI · Paper page
  118. Yuan, 2020, Near-Infrared Light-Triggered Nitric-Oxide-Enhanced Photodynamic Therapy and Low-Temperature Photothermal Therapy for Biofilm Elimination, ACS Nano, 14, 3546, 10.1021/acsnano.9b09871 · DOI · Paper page
  119. Sun, 2021, Near-infrared light triggered photodynamic and nitric oxide synergistic antibacterial nanocomposite membrane, Chem. Eng. J., 417, 128049, 10.1016/j.cej.2020.128049 · DOI · Paper page
  120. Zhu, 2021, L-Arg-Rich Amphiphilic Dendritic Peptide as a Versatile NO Donor for NO/Photodynamic Synergistic Treatment of Bacterial Infections and Promoting Wound Healing, Small, 17, 2101495, 10.1002/smll.202101495 · DOI
  121. Lu, 2013, Nitric Oxide-Releasing Amphiphilic Poly(amidoamine) (PAMAM) Dendrimers as Antibacterial Agents, Biomacromolecules, 14, 3589, 10.1021/bm400961r · DOI
  122. Backlund, 2014, Antibacterial Efficacy of Exogenous Nitric Oxide on Periodontal Pathogens, J. Dent. Res., 93, 1089, 10.1177/0022034514529974 · DOI
  123. Yang, 2018, Antibacterial Activity of Nitric Oxide-Releasing Hyperbranched Polyamidoamines, Bioconjug. Chem., 29, 35, 10.1021/acs.bioconjchem.7b00537 · DOI
  124. Storm, 2014, Superhydrophobic nitric oxide-releasing xerogels, Acta Biomater., 10, 3442, 10.1016/j.actbio.2014.04.029 · DOI
  125. Craven, 2016, Nitric oxide-releasing polyacrylonitrile disperses biofilms formed by wound-relevant pathogenic bacteria, J. Appl. Microbiol., 120, 1085, 10.1111/jam.13059 · DOI
  126. Fleming, G., Aveyard, J., Fothergill, J.L., McBride, F., Raval, R., and D’Sa, R.A. (2017). Nitric Oxide Releasing Polymeric Coatings for the Prevention of Biofilm Formation. Polymers, 9. · DOI
  127. Wo, 2017, Study of crystal formation and nitric oxide (NO) release mechanism from S-nitroso-N-acetylpenicillamine (SNAP)-doped CarboSil polymer composites for potential antimicrobial applications, Compos. Part B Eng., 121, 23, 10.1016/j.compositesb.2017.03.027 · DOI
  128. Singha, 2017, Enhanced antibacterial efficacy of nitric oxide releasing thermoplastic polyurethanes with antifouling hydrophilic topcoats, Biomater. Sci., 5, 1246, 10.1039/C6BM00948D · DOI
  129. Mondal, 2021, Highly hydrophobic polytetrafluoroethylene particle immobilization via polydopamine anchor layer on nitric oxide releasing polymer for biomedical applications, J. Colloid Interface Sci., 585, 716, 10.1016/j.jcis.2020.10.051 · DOI
  130. Homeyer, 2019, Liquid-Infused Nitric-Oxide-Releasing Silicone Foley Urinary Catheters for Prevention of Catheter-Associated Urinary Tract Infections, Acs Biomater. Sci. Eng., 5, 2021, 10.1021/acsbiomaterials.8b01320 · DOI
  131. Sadrearhami, 2019, Antibiofilm Nitric Oxide-Releasing Polydopamine Coatings, ACS Appl. Mater. Interfaces, 11, 7320, 10.1021/acsami.8b16853 · DOI
  132. Li, 2020, Nitric Oxide Releasing Titanium Surfaces for Antimicrobial Bone-Integrating Orthopedic Implants, ACS Appl. Mater. Interfaces, 12, 22433, 10.1021/acsami.0c00871 · DOI
  133. Sadrearhami, 2019, S-Nitrosothiol Plasma-Modified Surfaces for the Prevention of Bacterial Biofilm Formation, Acs Biomater. Sci. Eng., 5, 5881, 10.1021/acsbiomaterials.9b01063 · DOI
  134. Ke, C.-L., Deng, F.-S., Chuang, C.-Y., and Lin, C.-H. (2021). Antimicrobial Actions and Applications of Chitosan. Polymers, 13. · DOI · Paper page
  135. Cohen, E., and Merzendorfer, H. (2019). Alginate: Pharmaceutical and Medical Applications. Extracellular Sugar-Based Biopolymers Matrices, Springer International Publishing. · doi:10.1007/978-3-030-12919-4
  136. Urzedo, 2020, Cytotoxicity and Antibacterial Activity of Alginate Hydrogel Containing Nitric Oxide Donor and Silver Nanoparticles for Topical Applications, ACS Biomater. Sci. Eng., 6, 2117, 10.1021/acsbiomaterials.9b01685 · DOI
  137. Reighard, 2017, Role of Nitric Oxide-Releasing Chitosan Oligosaccharides on Mucus Viscoelasticity, ACS Biomater. Sci. Eng., 3, 1017, 10.1021/acsbiomaterials.7b00039 · DOI
  138. Rong, F., Tang, Y.Z., Wang, T.J., Feng, T., Song, J., Li, P., and Huang, W. (2019). Nitric Oxide-Releasing Polymeric Materials for Antimicrobial Applications: A Review. Antioxidants, 8. · DOI · Paper page
  139. Friedman, 2011, Improved antimicrobial efficacy with nitric oxide releasing nanoparticle generated S-nitrosoglutathione, Nitric Oxide, 25, 381, 10.1016/j.niox.2011.09.001 · DOI
  140. Li, 2019, Synergistic in vitro effects of indocyanine green and ethylenediamine tetraacetate-mediated antimicrobial photodynamic therapy combined with antibiotics for resistant bacterial biofilms in diabetic foot infection, Photodiagnosis Photodyn. Ther., 25, 300, 10.1016/j.pdpdt.2019.01.010 · DOI
  141. Biel, 2011, Antimicrobial photodynamic therapy treatment of chronic recurrent sinusitis biofilms, Int. Forum Allergy Rhinol., 1, 329, 10.1002/alr.20089 · DOI
  142. Biel, 2013, Photodynamic therapy of antibiotic-resistant biofilms in a maxillary sinus model, Int. Forum Allergy Rhinol., 3, 468, 10.1002/alr.21134 · doi:10.1002/alr.21134
  143. Caminade, 2015, Dendrimers and hyperbranched polymers, Chem. Soc. Rev., 44, 3870, 10.1039/C5CS90049B · DOI · Paper page
  144. Liu, 2021, Beta-Cyclodextrin-graft-poly(amidoamine) dendrons as the nitric oxide deliver system for the chronic rhinosinusitis therapy, Drug Deliv., 28, 306, 10.1080/10717544.2021.1876183 · DOI
  145. Yang, 2018, Nitric Oxide-Releasing Hyperbranched Polyaminoglycosides for Antibacterial Therapy, ACS Appl. Bio Mater., 1, 1066, 10.1021/acsabm.8b00304 · DOI
  146. Sun, 2012, Nitric oxide-releasing dendrimers as antibacterial agents, Biomacromolecules, 13, 3343, 10.1021/bm301109c · DOI
  147. Lopez, 2009, Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers, Mol. Biosyst., 5, 1148, 10.1039/b904746h · DOI
  148. Wang, 2010, Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers, Int. J. Pharm., 395, 298, 10.1016/j.ijpharm.2010.05.030 · DOI
  149. Devine, 2019, Versatile biomimetic medical device surface: Hydrophobin coated, nitric oxide-releasing polymer for antimicrobial and hemocompatible applications, Biomater. Sci., 7, 3438, 10.1039/C9BM00469F · DOI
  150. Clarke, 2005, Conformational Changes of Fibrinogen after Adsorption, J. Phys. Chem. B, 109, 22027, 10.1021/jp054456k · DOI
  151. Michl, 2015, Nitric oxide releasing plasma polymer coating with bacteriostatic properties and no cytotoxic side effects, Chem. Commun., 51, 7058, 10.1039/C5CC01722J · DOI
  152. Marxer, 2003, Preparation of nitric oxide (NO)-releasing sol-gels for biomaterial applications, Chem. Mater., 15, 4193, 10.1021/cm034347n · DOI
  153. Chen, 2010, Surface hydration: Principles and applications toward low-fouling/nonfouling biomaterials, Polymer, 51, 5283, 10.1016/j.polymer.2010.08.022 · DOI · Paper page
  154. Nablo, 2004, Poly(vinyl chloride)-Coated Sol−Gels for Studying the Effects of Nitric Oxide Release on Bacterial Adhesion, Biomacromolecules, 5, 2034, 10.1021/bm049727w · DOI

Cited by

Metadata

Authors
Poh, W. H., & Rice, S. A.
Venue
Molecules
Publisher
MDPI AG
Published
2022-01-20
Volume
27
Issue
3
Pages
674
ISSN
1420-3049
Cited by
114
References
22
Language
en
Funders
Ministry of Education (MOE2019-T2-1-050)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.